Ziyi Sun, Rongqi Li, Yingai Wang, Feng Han, Wei Wei, & Xin Li. (2023). Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationZiyi Sun, Rongqi Li, Yingai Wang, Feng Han, Wei Wei, and Xin Li. Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease. Adis, Springer Healthcare, 2023.
MLA (9th ed.) CitationZiyi Sun, et al. Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease. Adis, Springer Healthcare, 2023.
Warning: These citations may not always be 100% accurate.